Home / Newswire


Weedstocks Newswire Feed

Weedstocks news RSS feed

Up Cannabis Announces Memorandum of Understanding with British Columbia Liquor Distribution Branch (BCLDB)

2018-07-12 11:37:00

TORONTO, July 12, 2018 (GLOBE NEWSWIRE) -- Newstrike Brands Ltd. (TSX-V:HIP) ("Newstrike" or the "Company"), is pleased to announce that its wholly-owned subsidiary, Up Cannabis Inc. (“Up Cannabis”), has signed a Memorandum of Understanding with the British Columbia Liquor Distribution Branch (BCLDB) that will see a variety of Up Cannabis product sold via BCLDB-approved strategic retail partners and locations.

“This agreement is yet another significant achievement for Newstrike and a critical step in our strategy to position Up Cannabis as the preferred Canadian adult-use brand,” said Jay Wilgar, CEO of Newstrike and Up Cannabis. “British Columbia is a very important market for Up Cannabis and we are proud to supply the BCLDB with quality cannabis that will drive our sales and revenue.”

Up Cannabis is one of only 31 Licensed Producers who have met the BCLDB’s requirements for supply of adult-use cannabis upon legalization. The agreement is conditional upon the federal and provincial governments adopting the necessary regulatory framework.

For further information or to request an interview, please contact:

PM Rendon Director, Communications & Public Relations 365-773-5432 pm@up.ca


Read more

CannaRoyalty Announces Closing of $30 Million Private Placement

2018-07-12 10:00:14


All financial figures in Canadian Dollars ($) unless otherwise noted.

OTTAWA, July 12, 2018 /CNW/ - CannaRoyalty Corp. (CSE: CRZ) (OTCQX: CNNRF) ("CannaRoyalty" or the "Company"), a leading North American cannabis products and brands company, is pleased to announce that it has closed its previously-announced, fully marketed private placement of unsecured convertible debentures for raising aggregate gross proceeds of C$32,980,000 (the "Offering"). The Offering was comprised of up 30,000 unsecured convertible debentures (the "Convertible Debentures") of the Company at a price of $1,000 per Convertible Debenture (the "Offering Price"). The Agents (as defined below) also partially exercised their option to arrange for purchases of additional Convertible Debentures (the "Over-Allotment Option"), raising an additional $2.98 million in gross proceeds. The proceeds from the Financing will be primarily used by the Company to expand its footprint across California, as well as general corporate and working capital purposes.

Canaccord Genuity Corp. acted as lead agent for a syndicate of investment dealers, including Altacorp Capital Inc., Beacon Securities Ltd., Cormark Securities Inc., Sprott Private Wealth LP, Infor Financial Inc., and Mackie Research Capital Corporation (collectively, the "Agents").

"We believe that California is the most attractive cannabis brands market in the world. The Offering will enable CannaRoyalty to further expand its footprint by building-out additional cross state distribution infrastructure and manufacturing capabilities, to better position us to meet the strong consumer demand we are seeing in the market," noted Marc Lustig, CEO of CannaRoyalty.


Read more

Canopy Enters MOU with BC Liquor Distribution Branch to Supply British Columbian Market

2018-07-12 08:00:33

ALDERGROVE & DELTA, BC, July 12, 2018 /CNW/ - Continuing the theme of securing major supply agreements in every Canadian province and territory with announced supply plans, Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (the "Company" or "Canopy Growth") is proud to announce that cannabis grown in its Delta and Aldergrove facilities, its other sites across the country, and products from its CraftGrow partners will be sold in fine retailers, both government-operated and private, across the province of British Columbia post-prohibition.

Canopy Growth entered into a supply MOU with the BC Liquor Distribution Branch to make available 5,719 kg of high-quality cannabis products in the first 12-months following October 17, 2018. The quantity referenced is a delivery requirement agreed to in the MOU, not an internal allocation.

"Investing in a reliable, national production footprint early has made all the difference as provincial partners assess potential supply sources," said Mark Zekulin, President & Co-CEO. "We've established a strong presence in BC with state-of-the-art greenhouse facilities in Delta and Aldergrove and we can't wait to see the BC bud we're currently growing and harvesting at both sites readily available on store shelves."

The Company's supply commitments to seven provinces and one territory including New Brunswick, Newfoundland & Labrador, Prince Edward Island, Quebec, Yukon, Manitoba, Alberta, and now B.C., combine for a total of over 67,000 kilograms of premium cannabis products from whole-flower to oils and Softgels on an annualized basis.

Canopy Growth's national production platform includes facilities in seven provinces across Canada including its two BC Tweed greenhouses which combine 3 million sq. ft. of growing space. With over 2.4 million sq. ft. of facilities actively licensed and operating across the country, and the remainder of several sites ready and awaiting licensing, development continues to ensure full licensing is achieved in the near future to ensure sufficient supply across the country.


Read more

MYM Shelves Automatic Securities Disposition Plan

2018-07-12 08:00:30

VANCOUVER, British Columbia, July 12, 2018 /CNW/ -- MYM Nutraceuticals Inc., (CSE: MYM) (CSE: MYM.CN) (OTC: MYMMF) (the "Company" or "MYM") announces it has shelved the automatic securities disposition plan ("ASDP") which was announced on December 29, 2017. The Company sought relief in relation to certain insider filing requirements in connection with the ASDP through the Process of Exemptive Relief Applications in Multiple Jurisdictions with the British Columbia Securities Commission and the Ontario Securities Commission. While relief was granted on May 2, 2018, the Company has not entered into an administrative agreement with an independent securities broker to put the plan into effect. No Directors or Officers have sold shares under the planned ASDP.

About MYM Nutraceuticals Inc.

MYM Nutraceuticals Inc. is an innovative company focused on acquiring Health Canada licenses to produce and sell high-end medicinal cannabis supplements and topical products. MYM is a shareholder in two production projects in Quebec that are anticipated to have over 1.5 million square feet of production space. MYM is also a shareholder in two additional cannabis production projects in Australia and Colombia. The "Northern Rivers Project" in New South Wales, Australia is expected to have 1.2 million square feet of cannabis production space. In Colombia, MYM partner, Colombia Organica, currently hold a seed to sale license for low THC cannabis and are in the licensing process for the cultivation and production of high THC cannabis extracts. Plans are underway for MYM and Colombia Organica to build a cannabis production facility in the region. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors. MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE: MYM) (OTC: MYMMF) (FRA: 0MY) (DEU: 0MY) (MUN: 0MY) (STU: 0MY).


Rob Gietl, CEO MYM Nutraceuticals Inc.www.mym.ca


Read more

WeedMD Signs Cannabis Supply Agreement with the British Columbia Liquor Distribution Branch

2018-07-12 07:53:00

TORONTO, July 12, 2018 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE) (“WeedMD” or the “Company) is pleased to announce it has entered into a memorandum of understanding with the British Columbia (“BC”) Liquor Distribution Branch (“LDB”) to supply the province with high-quality, branded cannabis products for sale in BC’s adult-use market.

“BC is widely recognized for having one of the most mature and developed cannabis consumer markets in Canada. We are very proud that the province will be offering WeedMD’s quality products,” said Keith Merker, Chief Executive Officer of WeedMD. “As the provinces develop their cannabis retail strategies, we are emerging as a supplier to multiple distribution channels and categories. This deal is another step in our strategy to provide access to our products in emerging legal adult-use markets across the country.”

“We are thrilled to be reaching this significant milestone in developing a competitive wholesale assortment for non-medical cannabis,” said Blain Lawson, LDB’s general manager and CEO. “The volume, variety and quality of our product assortment speak to the LDB’s commitment to working towards eliminating the illicit market.”

WeedMD will supply the BC market with cannabis products at the advent of legal sales starting October 2018. This agreement represents another key milestone in WeedMD’s strategic plan to develop a national distribution platform for the Company’s medical and adult-use products, building upon the recent announcement of WeedMD’s respective supply agreements with the Alberta Gaming, Liquor and Cannabis Commission (AGLC) and Shoppers Drug Mart1. WeedMD is actively working with additional provincial distributors, regulators, and retailers to expand its adult-use distribution program, particularly as the Company completes the final stages of its 220,000 sq. ft. greenhouse retrofit within its 610,000 sq. ft. greenhouse facility in Strathroy, Ontario.

For more information, access our investor presentation here and corporate video here.


Read more

MedReleaf to Sponsor Cancer Trial in Collaboration with the Ontario Clinical Oncology Group

2018-07-12 07:00:30

In affiliation with Hamilton Health Sciences and the Department of Oncology at McMaster University

MARKHAM, ON, July 12, 2018 /CNW/ - MedReleaf Corp. (TSX:LEAF) ("MedReleaf" or the "Company"), in collaboration with the Ontario Clinical Oncology Group ("OCOG") today announced it will sponsor a cancer trial to improve the management of cancer pain using medical grade cannabis oil.

The OCOG directed by Dr. Mark Levine will coordinate the trial. Dr. Marissa Slaven, a specialist in pain management and palliative care is the Principal Investigator. The study will be conducted at the HHS Juravinski Cancer Centre in Hamilton over a one-two year period. Patients with cancer related pain will be administered MedReleaf's uniquely formatted cannabis oil capsules with the objective of improving pain management.

Cancer patients experiencing pain despite other pain medications may be eligible to participate. The aim of the trial is to assess the effect of cannabis oil in relieving their symptoms and to gain information on the best oral dosing regimen. Patients will receive an oil combining THC and CBD.

"Patients with cancer often suffer from significant pain and we know that while managing the pain with narcotics is often necessary, it is also fraught with issues," said Dr. Marissa Slaven. "Anecdotally, cancer patients have been telling us that cannabis products help their pain. Thanks to MedReleaf's commitment to advancing medical science we will now be able to start gathering the data needed to help our patients live better."


Read more

MedReleaf completes cannabis supply agreement with British Columbia Liquor Distribution Branch

2018-07-12 07:00:20

MARKHAM, ON, July 12, 2018 /CNW/ - MedReleaf Corp. (TSX:LEAF) ("MedReleaf" or the "Company"), today announced that it has entered into a Memorandum of Understanding ("MOU") with the British Columbia Liquor Distribution Branch ("BCLDB") to supply the Province with high quality adult recreational-use cannabis products.

MARKHAM, ON, July 12, 2018 /CNW/ - MedReleaf Corp. (TSX:LEAF) ("MedReleaf" or the "Company"), today announced that it has entered into a Memorandum of Understanding ("MOU") with the British Columbia Liquor Distribution Branch ("BCLDB") to supply the Province with high quality adult recreational-use cannabis products.

Under the terms of the MOU, MedReleaf has agreed to supply the BCLDB with cannabis products in a variety of formats including dried flower and capsules. MedReleaf will be represented on British Columbia's on-line and brick and mortar retail outlets under the San Rafael '71, AltaVie and Woodstock brands.

San Rafael '71 is inspired by and designed to celebrate the spirit of classic cannabis culture, aimed at discerning adults who are knowledgeable about cannabis products and who value quality and an authentic experience. AltaVie is designed for a premium consumer and those new to cannabis who are curious, selective and interested in general wellness and enrichment. Woodstock is an iconic brand and a trusted symbol of the lifestyles of the cannabis community; bringing to market quality products that embody the values of Woodstock.

"Partnering with the BC Liquor Distribution Branch in supplying adult recreational cannabis is a valuable opportunity for MedReleaf to expand our footprint across Canada," said Neil Closner, CEO of MedReleaf. "With an annual production capacity that will approach 140,000 kilograms, we are well equipped to meet the anticipated high demand that discerning BC consumers will have for the premium quality cannabis products that MedReleaf has become recognized for across Canada."


Read more

Hiku Brands Completes Supply Agreement in British Columbia

2018-07-12 07:00:00


Supply Will Be Grown by Hiku's DOJA facility in Kelowna, B.C.

TORONTO, July 12, 2018 /CNW/ - Hiku Brands Company Ltd. (CSE: HIKU) ("Hiku" or the "Company") has completed a supply agreement with the British Columbia Liquor Distribution Branch (BCLDB) to supply cannabis for the adult use market once legalization takes place in October, 2018.

"At DOJA, we believe that we cultivate exceptional hand-crafted cannabis to help people find their balance and actualize personal freedom. We are committed to minimizing our impact on nature with an eye towards natural, sustainable and innovative growing principles.  We are West Coast Contemporaries" said Trent Kitsch, President of Hiku and Co-Founder of DOJA, whose roots go back three generations in Kelowna.

Grown in one of Canada's premier wine regions, Hiku's Okanagan Valley cannabis brand is truly inspired by nature from the ground up.  DOJA is focused on producing top-quality, indoor grown cannabis to serve the adult market in Canada. Management believes its small capacity and craft cannabis production will find a premium place with Canada's active and healthy lifestyle communities.


Read more

CannaRoyalty Acquires Rights to Innovative Infused Pre-Roll Brand, Pacific Remedy

2018-07-12 07:00:00

OTTAWA, July 12, 2018 /CNW/ - CannaRoyalty Corp. (CSE: CRZ) (OTCQX: CNNRF) ("CannaRoyalty" or the "Company"), a leading North American cannabis products and brands company, announced today that it has acquired the exclusive rights to distribute and manufacture Pacific Remedy LLC's ("Pacific Remedy") industry-leading infused pre-rolls in California (the "Agreement"). The Agreement also provides CannaRoyalty with the option to purchase global brand rights (the "Option") for the premium infused pre-roll manufacturer.

"Brands are true value. Built through real consumer trust. They are our mission," said Marc Lustig, Chairman & CEO, CannaRoyalty.

"I founded this company over 3 years ago with a vision that brands would dominate the future of the cannabis industry. Brands represent the trust relationship formed through repeat sales to, and an ongoing conversation with, a consumer. Most jurisdictions, including our home jurisdiction of Canada, do not yet provide the right conditions for that trust to form. Conversely, I have found that there is no better place in the world than California to create that trust, which is why we are there; building the pre-eminent global cannabis brand growth platform."

Pacific Remedy is a California-based brand founded by Timothy Elze and Jon Rivera. Pacific Remedy's uniquely designed infused pre-rolls make them a differentiated manufacturer in the premium pre-roll category. In 2017, Pacific Remedy's products were carried in 13 cannabis dispensaries throughout the Bay Area and Southern California. Subsequent to this Agreement, Pacific Remedy will be able to sell its premium product through CannaRoyalty's distribution network, which covers the majority of California's approximately 500 licensed dispensaries.


Read more

Auxly Announces Director Resignation

2018-07-12 07:00:00

VANCOUVER, British Columbia, July 12, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V:XLY) ("Auxly" or the "Company") has announced today that following his appointment as Chief Executive Officer of a federal agency, Invest in Canada, Ian McKay has resigned as a director of the Company’s Board of Directors. The Company has initiated a search for a new director to replace Mr. McKay.

Chuck Rifici, Chairman and Chief Executive Officer of Auxly Cannabis Group commented, “On behalf of the Board of Directors and the Auxly team, I'd like to thank Ian for his valuable guidance and support over the past year. We wish him well in this exciting phase of public service. In my opinion, there's no one better than Ian to launch this agency and promote Canada as a premier destination for foreign direct investment.  Our loss is Canada's gain."

ON BEHALF OF THE BOARD "Chuck Rifici" Chairman & CEO

About Auxly Cannabis Group Inc. (TSX.V:XLY)

Auxly Cannabis Group is a collective of entrepreneurs with a passion for the cannabis industry past, present and future. Our mandate is to facilitate growth for our partners by providing them with financial support and sharing our collective industry experience. Our partners all have different visions, voices and brand values, and all share a common goal—to build a world-class industry based on ethics, diversity, quality and innovation.


Read more